Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 3/2010

01-06-2010 | Case Report

Kikuchi–Fujimoto disease developed into autoimmune disease: a report of two cases

Authors: Shohei Ogata, Yuki Bando, Norimitsu Saito, Kensei Katsuoka, Masahiro Ishii

Published in: Modern Rheumatology | Issue 3/2010

Login to get access

Abstract

We report herein the pathological findings and clinical courses of two cases of Kikuchi–Fujimoto disease (KFD) that developed into autoimmune diseases. The patients are currently undergoing treatment for a disease similar to Sjogren’s syndrome and systemic lupus erythematosus/mixed connective tissue disease. KFD is not an independent condition and most likely develops due to an autoimmune mechanism. Pediatricians should pay careful attention to KFD and encourage long-term follow-up in patients with this condition.
Literature
1.
Kikuchi M. Lymphadenitis showing focal reticular cell hyperplasia with nuclear debris and phagocytes. Acta Hematol Jpn. 1972;35:379–80 (in Japanese).
2.
Fujimoto Y, Kozima Y, Yamaguchi K. Cervical subacute necrotizing lymphadenitis. Naika. 1972;30:920–7 (in Japanese).
3.
4.
Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004;122:141–52.CrossRefPubMed
5.
Yen HR, Lin PY, Chuang WY, Chang ML, Chiu CH. Skin manifestations of Kikuchi-Fujimoto disease: case report and review. Eur J Pediatr. 2004;163:210–3.CrossRefPubMed
6.
Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M. Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol. 2007;26:50–4.CrossRefPubMed
7.
Park HS, Sung MJ, Park SE, Lim YT. Kikuchi-Fujimoto disease of 16 children in single center of Korea. Pediatr Allergy Immunol. 2007;18:174–8.CrossRefPubMed
8.
Ura H, Yamada N, Imakado S, Iozumi K, Shimada S. Histiocytic necrotizing lymphadenitis: the necrotic appearance of the lymph node is caused by apoptosis. J Dermatol. 1999;26:385–9.PubMed
9.
Paradela S, Lorenzo J, Martínez-Gómez W, Yebra-Pimentel T, Valbuena L, Fonseca E. Interface dermatitis in skin lesions of Kikuchi-Fujimoto’s disease: a histopathological marker of evolution into systemic lupus erythematosus? Lupus. 2008;17:1127–35.CrossRefPubMed
10.
Anagnostopoulos I, Hummel M, Korbjuhn P, Papadaki T, Anagnostou D, Stein H. Epstein-Barr virus in Kikuchi-Fujimoto disease. Lancet. 1993;341:893.CrossRefPubMed
11.
Johnson LB, Pasumarthy A, Saravolatz LD. Parvovirus B19 infection presenting with necrotizing lymphadenitis. Am J Med. 2003;14:340–1.CrossRef
12.
Cho KJ, Lee SS, Khang SK. Histiocytic necrotizing lymphadenitis. A clinicopathologic study of 45 cases with in situ hybridization for Epstein-Barr virus and hepatitis B virus. J Korean Med Sci. 1996;11:409–14.PubMed
13.
Chiu CF, Chow KC, Lin TY, Tsai MH, Shih CM, Chen LM. Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol. 2000;113:774–81.CrossRefPubMed
14.
Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin’s and Kikuchi’s diseases and their relation to proliferation and apoptosis. Anticancer Res. 2001;21:2155–61.PubMed
15.
Dominguez DC, Torres ML, Antony S. Is human herpesvirus 6 linked to Kikuchi-Fujimoto disease? The importance of consistent molecular and serologic analysis. Clin Immunol. 2005;114:27–9.CrossRef
16.
Jun-Fen F, Chin-Lin W, Li L, Dayan C, Guan-Ping D, Fang H, et al. Kikuchi-Fujimoto disease manifesting as recurrent thrombocytopenia and Mobitz type II atrioventricular block in a 7-year-old girl: a case report and analysis of 138 Chinese childhood Kikuchi-Fujimoto cases with 10 years of follow-up in 97 patients. Acta Pediatr. 2007;96:1844–7.CrossRef
17.
Mahajan T, Merriman RC, Stone MJ. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): report of a case with other autoimmune manifestations. Proc (Bayl Univ Med Cent). 2007;20:149–51.
18.
Lopez C, Oliver M, Olavarria R, Sarabia MA, Chopite M. Kikuchi-Fujimoto necrotizing lymphadenitis associated with cutaneous lupus erythematosus: a case report. Am J Dermatopathol. 2000;22:328–33.CrossRefPubMed
19.
Chen HC, Lai JH, Huang GS, Gao HW, Chen CH, Kuo SY, et al. Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto’s disease complicated with anti-phospholipid antibody syndrome: a case report and review of the literature. Rheumatol Int. 2005;25:303–6.CrossRefPubMed
20.
Poulose V, Chiam P, Poh WT. Kikuchi’s disease: a Singapore case series. Singap Med J. 2005;46:229–32.
21.
Soy M, Peynirci H, Bilgi S, Adali MK, Güresci S. Kikuchi-Fujimoto disease coexisted with Sjogren’s syndrome. Clin Rheumatol. 2007;26:607–8.CrossRefPubMed
22.
Miyashita Y, Yamaguchi M, Fujimoto W. Painful indurated erythema suggestive of Kikuchi-Fujimoto disease in a patient with primary Sjögren’s syndrome. J Dermatol. 2003;30(8):608–11.PubMed
Metadata
Title
Kikuchi–Fujimoto disease developed into autoimmune disease: a report of two cases
Authors
Shohei Ogata
Yuki Bando
Norimitsu Saito
Kensei Katsuoka
Masahiro Ishii
Publication date
01-06-2010
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 3/2010
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-009-0269-7

Other articles of this Issue 3/2010

Modern Rheumatology 3/2010 Go to the issue

Case Report

Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site

Erratum

Erratum to: Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus

Letter

A case of active rheumatoid arthritis with renal dysfunction treated effectively with tocilizumab monotherapy

Case Report

Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis

Original Article

Impact of biologics on the prevalence of orthopedic surgery in the National Database of Rheumatic Diseases in Japan

Original Article

Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits